Internal Medicine, Hematology · Boston, MA
NPI
1861469249
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
450 Brookline Ave
Boston, MA, 02215
Phone (617) 632-3667
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
160 services
Medicare patients, 2024
70
Average age 68
Drug cost, 2024
$3.8M
520 prescriptions
Company payments, 2025
$14K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph H Antin was code 99214 (office e&m - established), 118 times for 47 patients. In total Joseph H Antin billed 160 services in 6 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 118 | 47 | $77.64 | $9,162 |
| 99205 Office E&M - New | Facility | 13 | 13 | $151.79 | $1,973 |
By year: 2022 $31K for 345 services; 2023 $16K for 203 services; 2024 $13K for 160 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph H Antin prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 80 prescriptions and refills. In total Joseph H Antin wrote 520 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 80 | 80 | 15 | $1.3M |
| Rezurock Belumosudil Mesylate | 65 | 65 | 17 | $1.4M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 62 | 128 | 19 | $546 |
| Acyclovir Generic | 48 | 92 | 19 | $934 |
| Prednisone Generic | 32 | 67 | 13 | $434 |
| Ursodiol Generic | 23 | 33 | 19 | $3,478 |
| Fabhalta Iptacopan Hcl | 18 | 18 | Under 11 | $827K |
| Valacyclovir Valacyclovir Hcl | 15 | 33 | Under 11 | $910 |
| Tacrolimus Generic | 11 | 23 | Under 11 | $756 |
| Deferasirox Generic | 11 | 11 | Under 11 | $27K |
Brand drugs: 199 claims; generic drugs: 321 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph H Antin $14K ($14K in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Research & Development, LLC with $5,550.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.